MedPath
HSA Approval

BORACTIB POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL

SIN15243P

BORACTIB POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL

BORACTIB POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL

May 26, 2017

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

L01XX32

xl 01 xx 32

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

S.C. SINDAN-PHARMA S.R.L.

Active Ingredients

Bortezomib

3.5 mg/vial

Bortezomib
© Copyright 2025. All Rights Reserved by MedPath